December 26, 2019
December 26, 2019 –The U.S. FDA has approved updates to the product label for Zilretta® (triamcinolone
acetonide extended release injectable suspension), manufactured by Flexion Therapeutics. Zilretta is a
synthetic corticosteroid indicated for use as an intra-articular injection to manage osteoarthritis pain